Biotech

All Articles

ReNeuron leaving behind AIM swap after overlooking fundraising objective

.ReNeuron has actually joined the lengthy checklist of biotechs to leave behind London's goal securi...

MBX apply for IPO to take opposition to Ascendis in to phase 3

.MBX Biosciences has contributed to the latest spurt of IPO filings. The biotech, which submitted it...

FDA expands probing right into Lykos' MDMA trials: WSJ

.For Lykos Therapeutics as well as the company's potential MDMA-assisted treatment for post-traumati...

Gene publisher Tome laying off 131 laborers

.Merely days after genetics editor Tome Biosciences declared secret functional cuts, a clearer photo...

Repare gives up 25% of team as biotech halts preclinical R&ampD

.Repare Therapy is laying off a quarter of its own labor force as the oncology biotech lessen its ow...

J &amp J files for FDA confirmation of $6.5 B autoimmune drug

.Johnson &amp Johnson has actually taken yet another action toward realizing a gain on its own $6.5 ...

Gain's period 1 succeed paves method to prove Parkinson's medicine's worth

.Increase Rehabs has specified its own sights on proving the efficiency of its own Parkinson's ailme...

Actinogen files brand new stage 2 records to save depression medication

.Actinogen Medical's chances-- and sell rate-- have recoiled a little coming from previously this mo...

Pfizer and also Main include Quotient to multibillion-dollar equation

.Front Runner Pioneering and Pfizer have actually included Quotient right into their 10-program coll...

Bayer pens $547M contract to drive boundaries of noncoding RNA

.Bayer execs were eager to anxiety to Strong this summer season that the German pharma giant's appet...